


| Key | % Net Assets |
|---|---|
| 4.0% | |
| 3.6% | |
| 3.2% | |
| 2.8% | |
| 86.4% |
| Name | % Net Assets |
|---|---|
| GlaxoSmithKline PLC | 4.0% |
| Diageo PLC | 3.6% |
| Babcock International Group PLC | 3.2% |
| Cable & Wireless PLC | 2.8% |
| Smith & Nephew PLC | 2.8% |
| Unilever PLC | 2.5% |
| Melrose PLC | 2.4% |
| VT Group PLC | 2.2% |
| Chemring Group PLC | 2.2% |
| Reed Elsevier PLC | 2.1% |
No asset data available.
| Date | 02-Mar-2022 |
|---|---|
| NAV | 459.40p |
| Currency | GBP |
| Change | -8.70p |
| % | -1.86% |
| YTD change | 459.40p |
| YTD % | n/a |
| Fund Inception | 03/11/1989 |
|---|---|
| Fund Manager | Julie Dean |
| TER | 0.96 (30-Apr-2011) |
| Minimum Investment | |
|---|---|
| Initial | £1000000 |
| Additional | £500,000 |
| Savings | n/a |
| Charges | |
|---|---|
| Initial | n/a |
| Annual Mang't | 0.75% |
| Exit | n/a |
| Name | % |
|---|---|
| Standard deviation | 0.02 |
| Sharpe ratio | 0.12 |
You are here: research